|

Inebilizumab Clinical Trials

2 actively recruiting trials across 2 locations

No change since August 2026

Also known as: Uplizna®

Pipeline

Phase 2: 2

Top Sponsors

  • Amgen2

Indications

  • Active Refractory Rheumatoid Arthritis1
  • Systemic Lupus Erythematosus1
  • Lupus1
  • Arthritis1
  • Generalized Myasthenia Gravis1

Scottsdale, Arizona1 trial

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

HonorHealth Research and Innovation Institute

Phase 2

Philadelphia, Pennsylvania1 trial

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

The Childrens Hospital of Philadelphia

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.